Topics in Critical and Intensive Care, Addiction Medicine, Mental Health, Substance Abuse, and Obesity
7-Night Western Caribbean Cruise ConferenceRound-trip Miami, Florida
February 9 - 16, 2019
14 AMA PRA Category 1 Credit(s)™
14 Contact Hours
14 CE Credits for Psychologists
8 Hours of Pharmacology for NPs
$895 for Physicians, Attorneys, Psychologists, Doctors of Pharmacy & Dentists
$695 for Physician Assistants, Nurse Practitioners
$495 Nurses, Residents, Students & Others
BIAS FREE CME - No Commercial Support was provided for this CME activity.
Dr. Edward Fisher received his BA in Biology and PhD in Pharmaceutical Sciences from Temple University, Philadelphia, Pennsylvania, and his BS in Pharmacy at Temple University College of Pharmacy. His current position is Professor and Dean, College of Pharmacy, Marshall B. Ketchum University, 2575 Yorba Linda Blvd., Fullerton, California.
Dr. Fisher has been granted tenure at three different universities. His first academic position was at Southwestern Oklahoma State University College of Pharmacy where he was promoted to Associate Professor. Subsequently, he went on to help start up three new colleges of pharmacy Midwestern University-Glendale College of Pharmacy as Professor and Inaugural Department Chair of Pharmaceutical Sciences, The Daniel K Inouye College of Pharmacy, University of Hawaii at Hilo, as Professor and Associate Dean.
He also served as the Director of the MS in Clinical Psychopharmacology program. His current position is Professor and Dean, College of Pharmacy, Marshall B. Ketchum University, 2575 Yorba Linda Blvd., Fullerton, California.
Dr Fisher is licensed as a pharmacist in Arizona and Pennsylvania, and has practiced in a variety of clinical settings. He has devised and presented over 100 continuing education seminars and innovative NSF sponsored short courses. He is a past National Secretary of Rho Chi, the only pharmacy honor society, and recipient of the National Rho Chi Advisor of the Year award. In addition to his administrative responsibilities, he currently plans to continue teaching in his areas of expertise which includes: substances of abuses, nutrition, and the pharmacotherapy of mental disorders.
Mervyn Singer MB BS MD FRCP(Lon) FRCP(Edin) FFICM
Professor of Intensive Care Medicine
University College London
Head, Research Department of Clinical Physiology, Division of Medicine
Director, Bloomsbury Institute of Intensive Care Medicine
Editor-in-Chief, Intensive Care Medicine experimental (ICMx)
NIHR Senior Investigator 2009-2017
Mervyn Singer is Professor of Intensive Care Medicine at University College London, UK. He trained in medicine at St Bartholomew's Hospital Medical College, London and then undertook subsequent junior doctor posts in hospitals around the London area. He performed his doctorate research thesis developing a novel hemodynamic monitoring tool using esophageal Doppler ultrasonography; the subsequent technology (CardioQ) is now used in >30 countries worldwide. He then began formal critical care training in an academic rotation at University College London in 1989 and was appointed Professor in 2001.
He is Director of the Bloomsbury Institute of Intensive Care Medicine and runs a research group totaling 15 people performing bench-to-bedside research. Specific interests include sepsis and multi-organ failure, tissue oxygenation, infection, novel diagnostics and monitoring. Funding comes from the Wellcome Trust, UK Medical Research Council, European Union, and UK National Institute of Health Research (NIHR) among others. He has published widely, with multiple papers in the New England Journal of Medicine, Lancet and JAMA. Apart from the above-mentioned esophageal Doppler monitor, he has developed a novel tissue PO2 monitor (gauging the adequacy of tissue perfusion) entering clinical trials in 2016, and a novel drug inducing a 'suspended animation' state intended for ischaemia-reperfusion injury that is scheduled to go into man also in 2016. He is also the clinical lead investigator of studies on novel diagnostics for sepsis and infection, and the first intensivist to be appointed a Senior Investigator by the NIHR.
He lectures widely and has delivered four plenary lectures at the annual Congresses of the European Society of Intensive Care Medicine and the US Society of Critical Care Medicine. He has authored/edited several textbooks including the Oxford Textbook of Critical Care and the Oxford Handbook of Critical Care. He is currently Editor-in-Chief of Intensive Care Medicine Experimental (ICMx), co-chair of the new Sepsis Redefinitions Task Force, Council Member of the International Sepsis Forum, Critical Care Theme Lead of the NIHR Health Informatics Collaborative, and does 13 clinical on-call weeks per annum in the ICU.
Our staff can assist you with all your travel arrangements.
- Overview of substance use disorders (addiction) and diversion: epidemiology, etiology, diagnosis and pharmacological and pharmacokinetic properties of commonly abused substances - Part one
- Describe the scope of the problem of substance-related disorders (substance use, abuse, diversion)
- Overview of substance use disorders (addiction) and diversion: epidemiology, etiology, diagnosis and pharmacological and pharmacokinetic properties of commonly abused substances - Part two, and Consequences and Prevention of Substance Abuse and Addiction
- Distinguish the changes to diagnostic criteria between DSM-IV-TR to DSM-5 for substance-use disorders
- Pharmacotherapy for Substance Use Disorders - Ethanol, Nicotine, and Opioids
- Compare and contrast the efficacy of drugs used to treat substance use disorders
- Obesity and weight control including pharmacotherapy for both OTC and prescription drugs
- Compare and contrast the efficacy of drugs used for the short- and long-term treatment of obesity.
- Managing acute asthma
- Diagnose and manage acute asthma from basic care through to life-threatening presentation
- Managing sepsis
- Differentiate infection from sepsis; diagnose and manage sepsis
- De-stressing the critically ill patient
- Determine the physiological, psychological and pharmacological stresses inflicted during critical illness
- Managing diabetic emergencies
- Manage fluid, insulin and other aspects from a physiological perspective
- Don't believe everything you read!
- Using sepsis as an exemplar, to demonstrate how the literature often misleads, with evidence bias rather than evidence base
- Understanding lactate
- To appreciate the biochemical basis of hyperlactatemia, and its causes, and how this is applied to clinical practice
- Managing acute heart failure
- Apply physiological principles to managing heart failure, employing appropriate use of pharmacology
Accreditation: Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation: Continuing Education, Inc. designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Each physician should claim only the credit commensurate with the extent of their participation in the activity.
Osteopathic Physicians: This program is eligible for Category 2 credit with the American Osteopathic Association (AOA) .
Canadian Physicians: This activity is eligible for Section 1 credits in the Royal College’s Maintenance of Certification (MOC) Program . Participants must log into MAINPORT to claim this activity.
US or Canadian Family Physicians: Please let us know if you require AAFP Prescribed Credits.
Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Nurse Practitioners: can claim either ANCC Contact Hours or AMA PRA Category 1 Credits™ as needed.
Pharmacology credits are identified on individual activities.
Accredited status does not imply endorsement by Continuing Education, Inc./University at Sea or ANCC of any commercial products displayed or used with an activity.
Approval: Continuing Education, Inc. is approved by the American Psychological Association to sponsor continuing education for psychologists. Continuing Education, Inc. maintains responsibility for this program and its content.
Designation: As an organization approved by the American Psychological Association, Continuing Education, Inc. is offering this activity for a maximum of 14 hours of continuing education credit. Full attendance is required; no partial credit will be given for partial attendance.
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.
|DATE||PORT OF CALL||ARRIVE||DEPART|
|Sat Feb 09||Miami, Florida
|Sun Feb 10||Key West, Florida
||7:00 am||5:00 pm|
|Mon Feb 11||At Sea - Cruising
Lectures 8:00am - 12 Noon; 1:00pm - 4:00pm
|Tue Feb 12||Puerto Costa Maya, Mexico
||8:00 am||5:00 pm|
|Wed Feb 13||Cozumel, Mexico
||7:00 am||4:00 pm|
|Thu Feb 14||George Town, Cayman Islands
||10:00 am||6:00 pm|
|Fri Feb 15||At Sea - Cruising
Lectures 8:00am - 12 Noon; 1:00pm - 4:00pm
|Sat Feb 16||Miami, Florida
Please note that our shore excursions are operated separately and
independently of those offered by the cruise line.